Scilex Holding (SCLX) Cost of Revenue (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Cost of Revenue of $4.4 million for Q1 2026, up 221.32% year-over-year from $1.4 million in Q1 2025, and up 70.12% on a QoQ basis from $2.6 million in Q4 2025.

Scilex Holding (SCLX) Cost of Revenue (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Cost of Revenue for 5 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cost of Revenue rose 221.32% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $13.7 million (down 4.01% YoY), while the FY2025 annual figure was $10.6 million, down 36.49% from the prior year.
  • Cost of Revenue came in at $4.4 million for Q1 2026 at Scilex Holding, up from $2.6 million in the prior quarter.
  • The five-year high for Cost of Revenue was $4.7 million in Q4 2024, with the low at $1.1 million in Q1 2022.
  • Average Cost of Revenue over 5 years is $3.4 million, with a median of $3.6 million recorded in 2022.
  • Across the five-year window, Cost of Revenue sank 63.96% in 2025 and jumped 221.32% in 2026, its largest moves.
  • Year by year, Cost of Revenue stood at $4.5 million in 2022, then increased by 0.18% to $4.5 million in 2023, then rose by 3.76% to $4.7 million in 2024, then slumped by 44.28% to $2.6 million in 2025, then soared by 70.12% to $4.4 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $4.4 million, $2.6 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.58 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 8.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.22 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 2.68 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 4.20 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.74 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.45 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 3.55 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 4.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.45 Mn
Mar 31, 2026 4.45 Mn
Dec 31, 2025 2.61 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 3.33 Mn
Sep 30, 2025 3.33 Mn
Jun 30, 2025 3.27 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 1.38 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 4.69 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 3.77 Mn
Sep 30, 2024 3.77 Mn
Jun 30, 2024 4.39 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 3.84 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 4.52 Mn
Dec 31, 2023 4.52 Mn